Login
Navigate Fool.com
Will ARIA beat
the market?
Community Rating: 2 Stars: Unattractive

7.20 0.11 (1.48%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $7.09
Previous Close $7.10
Daily Range $6.97 - $7.37
52-Week Range $2.15 - $23.00
Market Cap $1.3B
P/E Ratio -4.83
Dividend (Yield) $0.00 (0.0%)
Volume 9,467,088
Average Daily Volume 12,189,298
Current FY EPS -$1.03

How do you think ARIA
will perform against the market?

Top ARIA Bull/Bear Pitches

 

JesusForgives (< 20)
Submitted April 1, 2010

This stock could just be a good pick to do a cover call option for may10 if my figures are right you could see a return of 14% for the month.

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted December 2, 2010

Ariad's share price has bounced around a lot this year in advance of data from the phase III SUCCEED trial of ridaforolimus in metastatic sarcoma, and is now close to a three year high (and a six-year … More

0 Replies Reply Report this Post

News & Commentary

3 Reasons an Ariad Pharmaceuticals Buyout Is Unlikely

Rumors continue to swirl that Ariad is a takeover target, but these three factors could eliminate any chance of that happening.

Is an Ariad Pharmaceuticals, Inc. Acquisition Realistic?

Jazz Pharmaceuticals, GlaxoSmithKline, and Eli Lilly have all been linked to Ariad Pharmaceuticals as potential acquirers, but will it actually occur?

Healthcare Stocks Falling Back to Near Even; Ariad Pharma Rises After Starting New Testing of Cancer

Healthcare Stocks Falling Back to Near Even; Ariad Pharma Rises After Starting New Testing of Cancer Drug

Sector Update: Healthcare

Morning Movers in Biotech: Ariad Pharmaceuticals, Exact Sciences Corporation and MannKind Corp

Today's top stories in biotech and health care.

SPDR S&P Biotech ETF Experiences Big Inflow

What's Next for Geron and Imetelstat?

A closer look at the promise and peril of Geron's imetelstat and the author's expectation of the most likely outcome from its current clinical hold.

Notable ETF Outflow Detected - XBI, ICPT, ITMN, ARIA

Friday's ETF with Unusual Volume: IBB

Noteworthy ETF Inflows: XBI, ICPT, ITMN, ARIA

See More ARIA News...

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks